ANTM

Anthem, Inc. [ANTM] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ANTM Stock Summary

In the News

06:00 29 Mar 2024 ANTM

LivaNova: Reaching End Of RECOVER And ANTHEM

LivaNova is approaching the end of the ANTHEM and RECOVER which could dramatically change the company profile. In cardiopulmonary results are great with a new product launch of Essenz taking market share at premium prices. Run-rate PEs aren't that high, and a languishing price means a setup here that could be attractive once the trials start to demonstrate concrete promise in 2024.

11:07 29 Mar 2024 ANTM

2 Healthcare Stocks That Could Help Set You Up for Life

These stocks could create significant wealth for shareholders in the long run.

05:31 29 Mar 2024 ANTM

Premiums, Deductibles, and Co-Pays: What Your Health Coverage Really Costs You

You're not entirely off the hook for healthcare costs after paying your insurance premiums. Here are a few other expenses to keep in mind.

02:10 29 Mar 2024 ANTM

Beyoncé's ‘Break My Soul' Heralded As Anthem For The Great Resignation

“Now I just fell in love/ And I just quit my job,” Beyoncé' sings on the dance track.

12:20 29 Mar 2024 ANTM

Anthem (ANTM) Unveils Two Brands to Boost Whole Person Health

Anthem (ANTM) launches Carelon and Wellpoint brands to streamline its products and services portfolio as well as bring about enhanced health plans for clients and consumers.

09:30 29 Mar 2024 ANTM

As Anthem Rebrands To Elevance, Healthcare Services To Be Named ‘Carelon'

Anthem's rebrand to Elevance Health will also include the new name of “Carelon” for its healthcare services and “Wellpoint” for certain health plans.

12:48 29 Mar 2024 ANTM

Anthem (ANTM) Ties Up to Improve Maternal Health Outcomes

Anthem (ANTM) teams up with Happify Health to bring a digital-first solution aimed at addressing issues stemming from the pregnancy experience and other health aspects of women.

12:02 29 Mar 2024 ANTM

Anthem (ANTM) Up 27% in a Year: Can It Retain the Momentum?

Anthem (ANTM) is well-poised for growth on sustained top-line improvement, membership increases in Government business and sturdy financial position.

12:03 29 Mar 2024 ANTM

5 HMO Stocks Set to Gain From Membership Growth, M&A Strategy

Rising membership and a rapidly growing aging U.S. population are likely to drive the performances of the Zacks Medical-HMO industry players. UNH, ANTM, HUM, CNC and SEM are poised to benefit from improved operational efficiencies.

03:43 29 Mar 2024 ANTM

Anthem's Gains Weaken The Bull Case

ANTM has returned 29% over the past year, as the company continues to turn in consensus-beating earnings. The Wall Street consensus outlook continues to be bullish, albeit with modest expectations implied by the 12-month price target.

ANTM Financial details

Company Rating
Strong Buy
Market Cap
114.59B
Income
5.99B
Revenue
171.34B
Book val./share
168.64
Cash/share
155.06
Dividend
6.07
Dividend %
1.17%
Employees
98.2K
Optionable
Yes
Shortable
Yes
Earnings
20 Jul 2022
P/E
36.33
Forward P/E
-
PEG
434.23
P/S
1.58
P/B
3.49
P/C
-
P/FCF
27.22
Quick Ratio
2.13
Current Ratio
2.2
Debt / Equity
0.64
LT Debt / Equity
0.59
-
-
EPS (TTM)
25.31
EPS next Y
-
EPS next Q
-
EPS this Y
0.48%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
6.04%
Revenue last 5Y
10.46%
Revenue Q/Q
-0.47%
EPS Q/Q
-33.76%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
100.54%
Inst Trans
0.97%
ROA
3%
ROE
10%
ROC
0.06%
Gross Margin
100%
Oper. Margin
6%
Profit Margin
4%
Payout
18%
Shs Outstand
237.46M
Shs Float
237.04M
-
-
-
-
Target Price
529.05
52W Range
466.74-485.745
52W High
-
52W Low
-
RSI
-
Rel Volume
1.08
Avg Volume
1.18M
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.973684
-
-
Volatility
10.86%, 10.86%
Prev Close
-
Price
-
Change
-

ANTM Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
412.04496.6568.66652.48726.32
Net income per share
19.0118.6325.2624.5625.38
Operating cash flow per share
23.9643.5534.313534.17
Free cash flow per share
19.7139.3929.8530.228.68
Cash per share
97.37118.88127.76138.91153.2
Book value per share
125.45135.28147.91151.28166.62
Tangible book value per share
10.18.575.277.0716.17
Share holders equity per share
125.45135.28147.91151.28166.62
Interest debt per share
82.3684.8497.74104.02110.85
Market cap
76.39B78.8B113.01B123.11B111.24B
Enterprise value
91.54B93.09B131.16B139.84B129.84B
P/E ratio
15.8917.2318.3520.8918.58
Price to sales ratio
0.730.650.820.790.65
POCF ratio
12.67.3713.5114.6613.8
PFCF ratio
15.338.1515.5316.9916.44
P/B Ratio
2.412.373.133.392.83
PTB ratio
2.412.373.133.392.83
EV to sales
0.880.760.950.890.76
Enterprise value over EBITDA
12.8612.5914.2214.8174.57
EV to operating cash flow
15.18.7115.6816.6516.11
EV to free cash flow
18.379.6318.0219.319.19
Earnings yield
0.060.060.050.050.05
Free cash flow yield
0.070.120.060.060.06
Debt to equity
0.630.60.640.660.64
Debt to assets
0.260.230.240.230.23
Net debt to EBITDA
2.131.931.971.7710.68
Current ratio
2.152.132.071.41.44
Interest coverage
8.027.969.939.130
Income quality
1.262.341.371.41.35
Dividend Yield
0.010.010.010.010.01
Payout ratio
0.170.210.180.210.23
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.380.360.360.340.33
Capex to operating cash flow
-0.18-0.1-0.13-0.14-0.16
Capex to revenue
-0.01-0.01-0.01-0.01-0.01
Capex to depreciation
-0.95-0.88-0.83-0.69-0.74
Stock based compensation to revenue
00000
Graham number
231.61238.14289.93289.12308.46
ROIC
0.090.080.10.10
Return on tangible assets
0.10.080.10.090.08
Graham Net
-109.56-135.24-160.76-111.24-182.92
Working capital
18.82B21.32B23.07B15.92B18.24B
Tangible asset value
2.55B2.1B1.29B1.7B3.82B
Net current asset value
-10.55B-13.28B-16.59B-10.76B-9.49B
Invested capital
0.630.60.640.660.64
Average receivables
9.93B10.76B12.2B14.74B16.95B
Average payables
12.73B14.95B17.67B19.56B21.83B
Average inventory
-27.3B-31.69B-36.41B-24.93B-28.86B
Days sales outstanding
36.9632.8235.3837.438.06
Days payables outstanding
2.39K687.03619.38577.7485.9
Days of inventory on hand
-5.32K-1.4K-1.29K-318.69-977.92
Receivables turnover
9.8811.1210.329.769.59
Payables turnover
0.150.530.590.630.75
Inventory turnover
-0.07-0.26-0.28-1.15-0.37
ROE
0.150.140.170.160.15
Capex per share
-4.26-4.16-4.46-4.8-5.49

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
167.8177.57184.58182.1182.98
Net income per share
3.998.377.835.483.67
Operating cash flow per share
-6.3827.248.2411.1-12.75
Free cash flow per share
-7.6325.976.769.75-14.15
Cash per share
140.1159.07160.66164.6155.06
Book value per share
152.58157.29161.48163.29168.64
Tangible book value per share
7.135.369.8711.7216.37
Share holders equity per share
152.58157.29161.48163.29168.64
Interest debt per share
102.3108.28107.29106.69108.89
Market cap
122.07B109.2B105.12B102.45B109.91B
Enterprise value
138.79B124.53B120.25B116.38B128.5B
P/E ratio
32.1613.7314.1819.8732.1
Price to sales ratio
3.062.592.412.392.58
POCF ratio
-80.4116.8853.9139.21-36.99
PFCF ratio
-67.2217.7165.744.66-33.34
P/B Ratio
3.362.922.752.672.8
PTB ratio
3.362.922.752.672.8
EV to sales
3.482.952.752.723.01
Enterprise value over EBITDA
99.0740.4241.8455.95286.19
EV to operating cash flow
-91.4319.2561.6744.54-43.25
EV to free cash flow
-76.4320.1975.1650.73-38.98
Earnings yield
0.010.020.020.010.01
Free cash flow yield
-0.010.060.020.02-0.03
Debt to equity
0.660.680.660.650.64
Debt to assets
0.230.230.230.220.23
Net debt to EBITDA
11.944.975.276.6941.41
Current ratio
1.41.431.441.411.44
Interest coverage
5.0410.439.356.390.1
Income quality
-1.583.231.052.01-3.58
Dividend Yield
00000
Payout ratio
0.320.180.190.270.4
Sales general and administrative to revenue
0.050000
Research and developement to revenue
00000
Intangibles to total assets
0.340.330.330.320.33
Capex to operating cash flow
0.2-0.05-0.18-0.120.11
Capex to revenue
-0.01-0.01-0.01-0.01-0.01
Capex to depreciation
-0.63-0.65-0.81-0.75-0.77
Stock based compensation to revenue
00000
Graham number
117.01172.16168.68141.87118.05
ROIC
0.020.030.030.020
Return on tangible assets
0.010.030.030.020.01
Graham Net
-112.19-116.76-102.14-163.01-201.6
Working capital
15.92B17.93B18.17B17.85B18.24B
Tangible asset value
1.7B1.27B2.34B2.76B3.82B
Net current asset value
-10.76B-11.76B-11.11B-10.75B-9.49B
Invested capital
0.660.680.660.650.64
Average receivables
15.13B16.38B16.62B16.73B17.4B
Average payables
20.42B20.62B20.9B21.68B22.59B
Average inventory
-26.38B-12.15B-10.18B-21.56B-44.85B
Days sales outstanding
36.1635.6634.0535.5637.7
Days payables outstanding
509.27532.63440.91429.07428.34
Days of inventory on hand
-280.94-334.15-154.56-691.15-1K
Receivables turnover
2.492.522.642.532.39
Payables turnover
0.180.170.20.210.21
Inventory turnover
-0.32-0.27-0.58-0.13-0.09
ROE
0.030.050.050.030.02
Capex per share
-1.25-1.27-1.48-1.36-1.4

ANTM Frequently Asked Questions

What is Anthem, Inc. stock symbol ?

Anthem, Inc. is a US stock , located in Indianapolis of Indiana and trading under the symbol ANTM

Is Anthem, Inc. buy or a sell ?

28 stock analysts have 28 predictions with a medium analyst target price of $519.29. The lowest prediction is $335 and the highest is $625

What is ANTM stock prediction ?

What is Anthem, Inc. stock quote today ?

Anthem, Inc. stock price is $- today.

Is Anthem, Inc. stock public?

Yes, Anthem, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Similar Market Cap